Login / Signup

Variables associated with poor health-related quality of life among patients with dyslipidemia in Jordan.

Anan S JarabEman A AlefishatWalid Al-QeremTareq L MukattashLina Abu-Zaytoun
Published in: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation (2021)
HRQOL has considerable scope for improvement in patients with dyslipidemia in Jordan. Improving dyslipidemia medications' beliefs and simplifying medication regimen by prescribing less medications, particularly for patients with longer disease duration and those on statin therapy, should be considered in future management programs aim at improving HRQOL in patients with dyslipidemia.
Keyphrases
  • primary care
  • public health
  • healthcare
  • coronary artery disease
  • adverse drug
  • type diabetes
  • stem cells
  • emergency department
  • mesenchymal stem cells
  • current status
  • cell therapy